Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Opdivo Could Extend Life of Mesothelioma Victims: Study February 3, 2021 Martha Garcia Add Your Comments Mesothelioma is a rare type of cancer caused by exposure to asbestos, and most individuals have a very short life expectancy by the time it is diagnosed. However, the findings of a new study indicate the cancer drug Opdivo may play a critical role in helping individuals with mesothelioma survive longer. In a study presented at the World Conference on Lung Cancer, British researchers indicate that patients who have mesothelioma and have exhausted traditional forms of treatment may survive months longer by taking Opdivo, providing signals for an important new treatment for the disease. Researchers included 332 patients in a clinical trial whose tumors were still growing after receiving chemotherapy, and the patients were not able to have surgery to treat their mesothelioma. A total of 221 patients were given Opdivo and 111 were given a placebo every two weeks for 12 months. Learn More About Mesothelioma Lawsuits Exposure to asbestos can cause the development of mesothelioma. Lawsuits have been filed nationwide against asbestos manufacturers. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Mesothelioma Lawsuits Exposure to asbestos can cause the development of mesothelioma. Lawsuits have been filed nationwide against asbestos manufacturers. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Opdivo, also known as nivolumab, is an immunotherapy drug approved to treat several other types of cancer. Last year, the FDA approved a combination of Opdivo and Yervoy to treat mesothelioma, despite earlier concerns regarding side effects, such as heart conditions and immune-related adverse events. It is the first drug approved for mesothelioma treatment in 16 years. In the new study, patients who were given Opdivo had an increased chance of survival compared to placebo patients. The findings suggest Opdivo made the disease more stable for patients who relapsed after receiving standard cancer treatment. Patients treated with Opdivo survived 9.2 months, compared to those given the placebo, who only survived 6.6 months longer. Furthermore, the risk of their cancer progressing was reduced by 39% and their cancer did not worsen for at least three months compared with 1.8 months in the placebo group. Mesothelioma is a particularly deadly form of cancer, as it is often at a very late stage by the time it is diagnosed. The only known cause is exposure to asbestos particles, and the cancer is often diagnosed decades later. Although most uses of asbestos have been banned in the United States, new mesothelioma cases continue to be diagnosed among former workers exposed to the toxic fibers, as well as children and family members who breathed the fibers carried home on work clothing or in the hair. Asbestos lawsuits have been one of the longest-running mass torts in the United States, involving thousands of claims brought against companies that manufactured or sold products containing the substance. Roughly 3,000 people are diagnosed with mesothelioma in the United States each year. Currently only 7% of people with mesothelioma survive the disease for five years or more. Patients are typically treated with chemotherapy, surgery or radiotherapy. Until now, there has been no treatment than can significantly improve outcomes for patients. This is the first study to indicate a treatment and offer improved survival for patients with mesothelioma that have relapsed after chemotherapy, researchers claim. “This trial shows clear evidence of benefit and marks a major breakthrough in the treatment of mesothelioma, a disease where there are currently very few options for patients when first-line chemotherapy has stopped working and prognosis is often very poor,” the researchers wrote. The findings were presented at the World Conference on Lung Cancer and are considered preliminary until published in a peer reviewed journal. Tags: Asbestos, Cancer, Mesothelioma, Opdivo More Mesothelioma Lawsuit Stories EPA Asbestos Risk Assessment Finds Firefighters, Construction Workers Face Highest Risks April 18, 2024 EPA Bans Last Uses of Toxic Asbestos in the United States March 19, 2024 U.S. Government Is Falling Behind Inspecting Federal Buildings for Toxic Asbestos, GAO Report Warns March 11, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: yesterday) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024) Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 2 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025) Judge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (Posted: 3 days ago) A California judge has ordered parties involved in a hair dye bladder cancer lawsuit filed against major cosmetic companies to meet for the first time this week to discuss the case. MORE ABOUT: HAIR DYE LAWSUITLawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)Hair Color Lawsuit Alleges Bladder Cancer Caused by Salon Dye (04/25/2025)
EPA Asbestos Risk Assessment Finds Firefighters, Construction Workers Face Highest Risks April 18, 2024
U.S. Government Is Falling Behind Inspecting Federal Buildings for Toxic Asbestos, GAO Report Warns March 11, 2024
Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: yesterday) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024)
Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 2 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)
Judge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (Posted: 3 days ago) A California judge has ordered parties involved in a hair dye bladder cancer lawsuit filed against major cosmetic companies to meet for the first time this week to discuss the case. MORE ABOUT: HAIR DYE LAWSUITLawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)Hair Color Lawsuit Alleges Bladder Cancer Caused by Salon Dye (04/25/2025)